| Chemical genetics of Plasmodium falciparum WA Guiguemde, AA Shelat, D Bouck, S Duffy, GJ Crowther, PH Davis, ... Nature 465 (7296), 311-315, 2010 | 659 | 2010 |
| A novel multiple-stage antimalarial agent that inhibits protein synthesis B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ... Nature 522 (7556), 315-320, 2015 | 465 | 2015 |
| A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria MA Phillips, J Lotharius, K Marsh, J White, A Dayan, KL White, ... Science translational medicine 7 (296), 296ra111-296ra111, 2015 | 342 | 2015 |
| Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors … JM Coteron, M Marco, J Esquivias, X Deng, KL White, J White, M Koltun, ... Journal of medicinal chemistry 54 (15), 5540-5561, 2011 | 328 | 2011 |
| (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium MB Jiménez-Díaz, D Ebert, Y Salinas, A Pradhan, AM Lehane, ... Proceedings of the National Academy of Sciences 111 (50), E5455-E5462, 2014 | 281 | 2014 |
| Cytokines in the pathogenesis of and protection against malaria I Angulo, M Fresno Clinical and Vaccine Immunology 9 (6), 1145-1152, 2002 | 270 | 2002 |
| Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis SG Franzblau, MA DeGroote, SH Cho, K Andries, E Nuermberger, ... Tuberculosis 92 (6), 453-488, 2012 | 264 | 2012 |
| Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase T Paquet, C Le Manach, DG Cabrera, Y Younis, PP Henrich, TS Abraham, ... Science translational medicine 9 (387), eaad9735, 2017 | 260 | 2017 |
| Quinolone-3-diarylethers: a new class of antimalarial drug A Nilsen, AN LaCrue, KL White, IP Forquer, RM Cross, J Marfurt, ... Science translational medicine 5 (177), 177ra37-177ra37, 2013 | 255 | 2013 |
| Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human … MB Jiménez-Díaz, T Mulet, S Viera, V Gómez, H Garuti, J Ibánez, ... Antimicrobial agents and chemotherapy 53 (10), 4533-4536, 2009 | 216 | 2009 |
| Nitric oxide-producing CD11b+Ly-6G(Gr-1)+CD31(ER-MP12)+cells in the spleen of cyclophosphamide–treated mice: implications for T-cell responses in … I Angulo, FG De Las Heras, JF Garcıa-Bustos, D Gargallo, ... Blood, The Journal of the American Society of Hematology 95 (1), 212-220, 2000 | 213 | 2000 |
| A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes I Angulo-Barturen, MB Jiménez-Díaz, T Mulet, J Rullas, E Herreros, ... PloS one 3 (5), e2252, 2008 | 197 | 2008 |
| Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum AB Vaidya, JM Morrisey, Z Zhang, S Das, TM Daly, TD Otto, NJ Spillman, ... Nature communications 5 (1), 5521, 2014 | 158 | 2014 |
| Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model ML Booker, CM Bastos, ML Kramer, RH Barker, R Skerlj, AB Sidhu, ... Journal of Biological Chemistry 285 (43), 33054-33064, 2010 | 158 | 2010 |
| Discovery of a potent and specific M. tuberculosis Leucyl-tRNA synthetase inhibitor:(S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy) benzo [c][1, 2] oxaborol-1 (3 H)-ol (GSK656) X Li, V Hernandez, FL Rock, W Choi, YSL Mak, M Mohan, W Mao, Y Zhou, ... Journal of medicinal chemistry 60 (19), 8011-8026, 2017 | 151 | 2017 |
| Tetrahydropyrazolo [1, 5-a] pyrimidine-3-carboxamide and N-benzyl-6′, 7′-dihydrospiro [piperidine-4, 4′-thieno [3, 2-c] pyran] analogues with bactericidal efficacy against … MJ Remuiñán, E Pérez-Herrán, J Rullás, C Alemparte, M Martínez-Hoyos, ... PloS one 8 (4), e60933, 2013 | 151 | 2013 |
| A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission DA Baker, LB Stewart, JM Large, PW Bowyer, KH Ansell, ... Nature communications 8 (1), 430, 2017 | 137 | 2017 |
| Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium … L Encinas, H O’Keefe, M Neu, MJ Remuiñán, AM Patel, A Guardia, ... Journal of Medicinal Chemistry 57 (4), 1276-1288, 2014 | 123 | 2014 |
| Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis B Baragaña, B Forte, R Choi, S Nakazawa Hewitt, JA Bueren-Calabuig, ... Proceedings of the National Academy of Sciences 116 (14), 7015-7020, 2019 | 119 | 2019 |
| Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia T Gumbo, I Angulo-Barturen, S Ferrer-Bazaga The Journal of infectious diseases 211 (suppl_3), S96-S106, 2015 | 119 | 2015 |
